Study involves researchers with UW International Clinical Research Center

By Bobbi Nodell

Researchers have found that breastfeeding mothers taking the antiretroviral drugs tenofovir and emtricitabine have a low risk of side effects. The study, published in PLOS, was conducted by colleagues at the UW International Clinical Research Center and partners in Kenya, Uganda and Johns Hopkins University.

In the 2016 Academic Ranking of World Universities for clinical medicine and pharmacy, the University of Washington has moved up to No. 2 in the world (from No. 3 in 2015) and is now second to only Harvard University.

The list, published by the Shanghai Ranking Consultancy, evaluates more than 1,200 universities. Shanghai Ranking is recognized for basing its rankings on objective indicators, such as the number of alumni and staff who have won Nobel Prizes, highly cited researchers and publications in top medical journals.

By 8:30 most mornings, Carey Farquhar has already exercised, dropped her kids at school and taken part in at least two calls with colleagues in Kenya. A ground-breaking HIV researcher and long-time mentor, she hopes to develop a more diverse student body as well as launch more fieldwork opportunities for students in Asia. She was recently named associate chair for academic programs in the Department of Global Health.

Research Passion: Promoting HIV testing within couples in Africa

By Bruce Jancin

DURBAN, SOUTH AFRICA – Oral antiretroviral pre-exposure prophylaxis (PrEP) against HIV also reduces the risk of acquiring herpes simplex virus type 2, according to research presented at the 21st International AIDS Conference.

“Given the limited interventions for primary prevention of HSV-2, efficacy against HSV-2 provides additional benefit to oral PrEP,” observed Connie Celum, MD, professor of global health and medicine at the University of Washington, Seattle.